Intervention News

Investing in the financial markets is a complex endeavor influenced not only by economic factors and market dynamics but also by human behavior.

PHILADELPHIA — In patients with stable angina and evidence of ischemia, PCI improved angina symptoms at 12 weeks compared with a sham procedure, according to the results from the ORBITA-2 trial.

PHILADELPHIA — In patients with acute MI and anemia, there was no difference between liberal and restrictive transfusion strategies for the composite outcome of death and MI at 30 days, according to results of the MINT trial.

Healio and Cardiology Today have aggregated news you may have missed from TCT 2023 in San Francisco.

The Healio team is providing live coverage of the American Heart Association's Scientific Sessions in Philadelphia.

SAN FRANCISCO — The first-time application of a triple-drug, site-specific antithrombotic therapy on a stent platform was safe and effective for managing thrombotic and bleeding risk after PCI, data presented at TCT 2023 show.

Active cancer during transcatheter aortic valve replacement did not increase in-hospital mortality, but certain cancer types were tied to elevated rehospitalization and major bleeding risk in the following months, researchers reported.

Healio released a new resource for health care providers who are interested in using Threads, the newest social media platform.

President Joe Biden recently announced an executive order to establish standards for artificial intelligence safety, equity and security in health care and several other industries.

The FDA approved the first renal denervation device to treat adults with hypertension not adequately controlled with lifestyle changes and medications, ReCor Medical announced.